Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	BNTXBiontech SE	INCYIncyte	MRNAModerna
Snapshot
Price	$108.79	$128.31	$140.48
Market cap	$24.67B	$23.35B	$31.65B
Valuation
P/E	—	17.7x	—
Forward P/E	—	12.6x	—
Growth
Revenue growth	-11.8%	21.5%	-30.0%
EPS growth	—	2455.3%	—
Profitability
Net margin	-34.0%	26.7%	-143.6%
ROE	-6.7%	29.2%	-36.7%
Balance sheet & cash
Debt / equity	0.01x	0.01x	0.07x
Free cash flow yield	13.6%	2.2%	-13.6%
Dividend yield	—	—	—
Verdict
Investment rating	Weak· 31	Strong· 86	Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	BNTXtoday $109	INCYtoday $128	MRNAtoday $140
2027	$83.22 – $122.06+12% CAGR	$2,459.04 – $3,606.59+2711% CAGR	$107.47 – $157.62+12% CAGR
2028	$84.89 – $124.50+7% CAGR	$62,836.06 – $92,159.56+2580% CAGR	$109.62 – $160.77+7% CAGR
2029	$86.59 – $126.99+5% CAGR	$1,605,656.17 – $2,354,962.38+2538% CAGR	$111.81 – $163.99+5% CAGR
2030	$88.32 – $129.53+4% CAGR	$41,029,492.63 – $60,176,589.19+2517% CAGR	$114.05 – $167.27+4% CAGR
2031	$90.08 – $132.12+4% CAGR	$1,048,430,728.12 – $1,537,698,401.25+2504% CAGR	$116.33 – $170.61+4% CAGR
5-yr CAGR	-3.7% – 4.0%	2312.4% – 2504.5%	-3.7% – 4.0%